Clinical Trials in Cairns, Queensland
23 recruiting
Showing 1–20 of 22 trials
Recruiting
Phase 2Phase 3
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis
End-stage Kidney DiseaseAtherosclerotic Cardiovascular DiseaseAtherosclerotic Cardiovascular Disease in Patients With ESKD
CSL Behring2,310 enrolled542 locationsNCT05485961
Recruiting
Phase 3
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Triple-Negative Breast Cancer
Gilead Sciences1,514 enrolled339 locationsNCT05633654
Recruiting
Phase 4
Staphylococcus Aureus Network Adaptive Platform Trial
Staphylococcus Aureus Bacteremia
University of Melbourne8,000 enrolled161 locationsNCT05137119
Recruiting
Phase 3
Duration of Anti-PD-1 Therapy in Metastatic Melanoma
Unresectable/Metastatic Melanoma
Canadian Cancer Trials Group614 enrolled30 locationsNCT02821013
Recruiting
Phase 3
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular RiskAcute Myocardial Infarction (AMI)
Novo Nordisk A/S10,000 enrolled970 locationsNCT06118281
Recruiting
The Australian HCV Point-of-Care Testing Program
Hepatitis C
Kirby Institute60,000 enrolled69 locationsNCT05042544
Recruiting
Phase 3
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
Intellia Therapeutics1,200 enrolled132 locationsNCT06128629
Recruiting
Phase 3
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Extensive-stage Small-cell Lung Cancer
BioNTech SE621 enrolled138 locationsNCT06712355
Recruiting
Phase 3
Fibrinogen Early In Severe Trauma StudY II
coagulopathyTraumaHaemorrhagic Shock
Australian and New Zealand Intensive Care Research Centre900 enrolled24 locationsNCT05449834
Recruiting
IMmune checkPoint Inhibitor Related gonAdal toxiCiTy in Premenopausal Women and Men With Melanoma
Melanoma (Skin Cancer)
Peter MacCallum Cancer Centre, Australia80 enrolled6 locationsNCT07138222
Recruiting
Atypical Hemolytic-Uremic Syndrome (aHUS) Registry
Atypical Hemolytic Uremic Syndrome
Alexion Pharmaceuticals, Inc.3,000 enrolled141 locationsNCT01522183
Recruiting
Not Applicable
Guideline Oriented Approach To Lipid Lowering In Asia-Pacific
Cardiovascular DiseasesAcute Coronary SyndromeAtherosclerosis+1 more
Stephen Nicholls2,000 enrolled22 locationsNCT05325034
Recruiting
Phase 3
Better Evidence and Translation for Calciphylaxis
Calciphylaxis
University of Sydney350 enrolled21 locationsNCT05018221
Recruiting
Phase 3
ErythroPOietin Alfa to Prevent Mortality and Reduce Severe Disability in Critically Ill TRAUMA Patients
Multiple traumaTraumatic Brain InjuryWounds and Injuries+5 more
Australian and New Zealand Intensive Care Research Centre2,500 enrolled41 locationsNCT04588311
Recruiting
Not Applicable
Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)
Kidney Failure, ChronicHyperphosphatemia
The University of Queensland3,600 enrolled115 locationsNCT03573089
Recruiting
Real World Assessment of People Living With Chronic Hepatitis B in Australia
Hepatitis B
Kirby Institute10,000 enrolled19 locationsNCT04914611
Recruiting
Phase 2
Tiragolumab and Atezolizumab in Advanced Pan-cancer Patients
Solid Tumor, Adult
Omico96 enrolled13 locationsNCT06003621
Recruiting
The National Australian HCV Point-of-Care Testing Program - HCV Antibody Testing Minimal Dataset
Hepatitis C
Kirby Institute40,000 enrolled12 locationsNCT05713136
Recruiting
The National Australian HCV Point-of-Care Testing Program - Minimal Dataset
Hepatitis C
Kirby Institute40,000 enrolled11 locationsNCT05248555
Recruiting
Not Applicable
Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator (ICD) Implantation to Prevent Tachyarrhythmias Following Acute Myocardial Infarction (PROTECT-ICD)
Sudden Cardiac Death
Western Sydney Local Health District1,058 enrolled52 locationsNCT03588286